Gene · 3767
Papers4,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Congenital Hyperinsulinaemic Hypoglycaemia-A Review and Case Presentation. | J Clin Med | 2022 | 36294341 | PubTator, text mining | PubMed |
| Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension. | Biomolecules | 2022 | 36291551 | PubTator, text mining | PubMed |
| Progress in the Development of Detection Strategies Based on Olfactory and Gustatory Biomimetic Biosensors. | Biosensors (Basel) | 2022 | 36290995 | PubTator, text mining | PubMed |
| Cellular Mechanisms of Coronary Artery Spasm. | Biomedicines | 2022 | 36289612 | PubTator, text mining | PubMed |
| High altitude differentially modulates potassium channel-evoked vasodilatation in pregnant human myometrial arteries. | J Physiol | 2022 | 36286320 | PubTator, text mining | PubMed |
| A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma. | BMC Med Inform Decis Mak | 2022 | 36273131 | PubTator, text mining | PubMed |
| Wnt4 is heterogeneously activated in maturing β-cells to control calcium signaling, metabolism and function. | Nat Commun | 2022 | 36271049 | PubTator, text mining | PubMed |
| Genetic variation in DPP-IV gene linked to predisposition of T2DM: A case control study. | J Diabetes Metab Disord | 2022 | 36249912 | PubTator, text mining | PubMed |
| Biomarkers: Tools for Discriminating MODY from Other Diabetic Subtypes. | Indian J Endocrinol Metab | 2022 | 36248040 | PubTator, text mining | PubMed |
| Transfer RNA-derived small RNAs and their potential roles in the therapeutic heterogeneity of sacubitril/valsartan in heart failure patients after acute myocardial infarction. | Front Cardiovasc Med | 2022 | 36247465 | PubTator, text mining | PubMed |
| Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management. | Front Endocrinol (Lausanne) | 2022 | 36246880 | PubTator, text mining | PubMed |
| Somatostatin receptors in congenital hyperinsulinism: Biology to bedside. | Front Endocrinol (Lausanne) | 2022 | 36237195 | PubTator, text mining | PubMed |
| Novel genes and variants associated with congenital pituitary hormone deficiency in the era of next-generation sequencing. | Front Endocrinol (Lausanne) | 2022 | 36237189 | PubTator, text mining | PubMed |
| Milk Exosomal microRNAs: Postnatal Promoters of β Cell Proliferation but Potential Inducers of β Cell De-Differentiation in Adult Life. | Int J Mol Sci | 2022 | 36232796 | PubTator, text mining | PubMed |
| Potassium Ion Channels in Malignant Central Nervous System Cancers. | Cancers (Basel) | 2022 | 36230692 | PubTator, text mining | PubMed |
| Congenital hyperinsulinism in clinical practice: From biochemical pathophysiology to new monitoring techniques. | Front Pediatr | 2022 | 36210928 | PubTator, text mining | PubMed |
| Statistical evidence for high-penetrance MODY-causing genes in a large population-based cohort. | Endocrinol Diabetes Metab | 2022 | 36208030 | PubTator, text mining | PubMed |
| A novel glucagon analog with an extended half-life, HM15136, normalizes glucose levels in rodent models of congenital hyperinsulinism. | Sci Rep | 2022 | 36202918 | PubTator, text mining | PubMed |
| Case report: A particularly rare case of endogenous hyperinsulinemic hypoglycemia complicated with pregnancy treated with short-acting somatostatin analog injections. | Front Endocrinol (Lausanne) | 2022 | 36187120 | PubTator, text mining | PubMed |
| A new mutation c.685G>A:p.E229K in the KCNJ11 gene: A case report of maturity-onset diabetes of the young13. | Medicine (Baltimore) | 2022 | 36181023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3767/papers?page=28